Pegylated Factor VIII
    5.
    发明申请
    Pegylated Factor VIII 有权
    聚乙二醇化因子VIII

    公开(公告)号:US20100168391A1

    公开(公告)日:2010-07-01

    申请号:US12719265

    申请日:2010-03-08

    IPC分类号: C07K14/755

    摘要: The invention is a proteinaceous construct comprising a Factor VIII molecule having at least a portion of the B domain intact, which is conjugated to a water-soluble polymer such as polyethylene glycol having a molecular weight of greater than 10,000 Daltons. The construct has a biological activity of at least 80% of the biological activity of native Factor VIII, and the in vivo half-life of the construct is increased by at least 1.5 fold as compared to the in vivo half-life of native factor FVIII.

    摘要翻译: 本发明是包含具有至少一部分B结构域的因子VIII分子的蛋白质构建体,其与水溶性聚合物如分子量大于10,000道尔顿的聚乙二醇缀合。 该构建体具有天然因子VIII的生物活性的至少80%的生物活性,与天然因子FVIII的体内半衰期相比,构建体的体内半衰期增加至少1.5倍 。

    Pegylated factor VIII
    6.
    发明申请
    Pegylated factor VIII 有权
    聚乙二醇化因子VIII

    公开(公告)号:US20070244301A1

    公开(公告)日:2007-10-18

    申请号:US11729625

    申请日:2007-03-29

    IPC分类号: C07K14/745

    摘要: The invention is a proteinaceous construct comprising a Factor VIII molecule having at least a portion of the B domain intact, which is conjugated to a water-soluble polymer such as polyethylene glycol having a molecular weight of greater than 10,000 Daltons. The construct has a biological activity of at least 80% of the biological activity of native Factor VIII, and the in vivo half-life of the construct is increased by at least 1.5 fold as compared to the in vivo half-life of native factor FVIII.

    摘要翻译: 本发明是包含具有至少一部分B结构域的因子VIII分子的蛋白质构建体,其与水溶性聚合物如分子量大于10,000道尔顿的聚乙二醇缀合。 该构建体具有天然因子VIII的生物活性的至少80%的生物活性,与天然因子FVIII的体内半衰期相比,构建体的体内半衰期增加至少1.5倍 。

    Pegylated factor VIII
    8.
    发明授权
    Pegylated factor VIII 有权
    聚乙二醇化因子VIII

    公开(公告)号:US08053561B2

    公开(公告)日:2011-11-08

    申请号:US12719265

    申请日:2010-03-08

    摘要: The invention is a proteinaceous construct comprising a Factor VIII molecule having at least a portion of the B domain intact, which is conjugated to a water-soluble polymer such as polyethylene glycol having a molecular weight of greater than 10,000 Daltons. The construct has a biological activity of at least 80% of the biological activity of native Factor VIII, and the in vivo half-life of the construct is increased by at least 1.5 fold as compared to the in vivo half-life of native factor FVIII.

    摘要翻译: 本发明是包含具有至少一部分B结构域的因子VIII分子的蛋白质构建体,其与水溶性聚合物如分子量大于10,000道尔顿的聚乙二醇缀合。 该构建体具有天然因子VIII的生物活性的至少80%的生物活性,与天然因子FVIII的体内半衰期相比,构建体的体内半衰期增加至少1.5倍 。

    Pegylated factor VIII
    9.
    发明授权
    Pegylated factor VIII 有权
    聚乙二醇化因子VIII

    公开(公告)号:US07683158B2

    公开(公告)日:2010-03-23

    申请号:US11729625

    申请日:2007-03-29

    IPC分类号: C07K14/745

    摘要: The invention is a proteinaceous construct comprising a Factor VIII molecule having at least a portion of the B domain intact, which is conjugated to a water-soluble polymer such as polyethylene glycol having a molecular weight of greater than 10,000 Daltons. The construct has a biological activity of at least 80% of the biological activity of native Factor VIII, and the in vivo half-life of the construct is increased by at least 1.5 fold as compared to the in vivo half-life of native factor FVIII.

    摘要翻译: 本发明是包含具有至少一部分B结构域的因子VIII分子的蛋白质构建体,其与水溶性聚合物如分子量大于10,000道尔顿的聚乙二醇缀合。 该构建体具有天然因子VIII的生物活性的至少80%的生物活性,与天然因子FVIII的体内半衰期相比,构建体的体内半衰期增加至少1.5倍 。